0001615219-20-000106.txt : 20201105
0001615219-20-000106.hdr.sgml : 20201105
20201105174403
ACCESSION NUMBER: 0001615219-20-000106
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201103
FILED AS OF DATE: 20201105
DATE AS OF CHANGE: 20201105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arthur David J.
CENTRAL INDEX KEY: 0001769331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36812
FILM NUMBER: 201291742
MAIL ADDRESS:
STREET 1: 2450 HOLCOME BLVD.
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001615219
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465087339
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
BUSINESS PHONE: 346-772-0346
MAIL ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
FORMER COMPANY:
FORMER CONFORMED NAME: Flex Pharma, Inc.
DATE OF NAME CHANGE: 20140730
4
1
wf-form4_160461622928134.xml
FORM 4
X0306
4
2020-11-03
0
0001615219
Salarius Pharmaceuticals, Inc.
SLRX
0001769331
Arthur David J.
C/O SALARIUS PHARMACEUTICALS, INC.
2450 HOLCOME BLVD., SUITE X
HOUSTON
TX
77021
1
1
0
0
Chief Executive Officer
Common Stock
2020-11-03
4
A
0
4879
0.561
A
86425
D
The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuant to the issuer's Employee Stock Purchase Plan.
/s/Mark Rosenblum, as Attorney-in-Fact
2020-11-05